COMMUNIQUÉ DE PRESSE publié le 24/01/2024 à 14:00, il y a 1 année 10 mois AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement AiCuris and the German Center for Infection Research (DZIF) have signed a collaboration and license option agreement to discover new active agents for the treatment and prophylaxis of infections of immunocompromised patients. The partnership aims to develop novel therapies for patients with high medical need. The financial details of the collaboration were not disclosed. For more information, visit www.dzif.de and www.aicuris.com. AiCuris German Center For Infection Research Collaboration License Option Agreement Immunocompromised Patients
COMMUNIQUÉ DE PRESSE publié le 28/09/2023 à 14:00, il y a 2 années 2 mois AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients
COMMUNIQUÉ DE PRESSE publié le 23/08/2023 à 14:00, il y a 2 années 3 mois AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication
COMMUNIQUÉ DE PRESSE publié le 06/07/2023 à 14:00, il y a 2 années 5 mois AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients
COMMUNIQUÉ DE PRESSE publié le 04/04/2023 à 14:00, il y a 2 années 8 mois AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary
Publié le 19/12/2025 à 21:57, il y a 1 heure 46 minutes Mise à disposition du document d’enregistrement universel
Publié le 19/12/2025 à 08:30, il y a 15 heures 14 minutes Share capital decrease by way of treasury shares cancellation
Publié le 19/12/2025 à 08:30, il y a 15 heures 14 minutes Réduction du capital par voie d’annulation d’actions propres
Publié le 19/12/2025 à 07:00, il y a 16 heures 44 minutes EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Publié le 19/12/2025 à 07:00, il y a 16 heures 44 minutes EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Publié le 19/12/2025 à 22:00, il y a 1 heure 44 minutes GMV Minerals Inc. Closes Non-Brokered Equity Financing
Publié le 19/12/2025 à 18:30, il y a 5 heures 14 minutes Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Publié le 19/12/2025 à 14:40, il y a 9 heures 4 minutes Northern Superior Announces Closing of the Arrangement
Publié le 19/12/2025 à 13:30, il y a 10 heures 14 minutes Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Publié le 19/12/2025 à 13:30, il y a 10 heures 14 minutes DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition
Publié le 19/12/2025 à 22:03, il y a 1 heure 40 minutes EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Publié le 19/12/2025 à 21:40, il y a 2 heures 3 minutes IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Publié le 19/12/2025 à 20:35, il y a 3 heures 8 minutes Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy
Publié le 19/12/2025 à 19:56, il y a 3 heures 47 minutes Original-Research: European Lithium Limited (von First Berlin Equity Research GmbH): Buy
